optic neuropathy semaglutide NAION Network Study Announcement A new study suggests patients

SKU: 90363423550

Pay in 4 interest-free payments of $5.87 Learn more

Live Spec

A new study suggests patients taking semaglutide the active ingredient in Ozempic and Wegovy may be at higher risk of developing an eye condition that can cause blindness. Non arteritic anterior Semaglutide May Raise Risk for NAION, Does Not Impact Risk for DR Use of semaglutide linked to doubled risk of neovascular macular degeneration Risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients prescribed semaglutide Novo Nordisk Medical Update Online Semaglutide linked to sight threatening optic stroke Medical Republic

Store: live-language.pl · Domain: live-language.pl